Connect with us

Health

No Proven Link Between Paracetamol Use in Pregnancy and Autism or ADHD, Major Review Finds

Published

on

A new comprehensive review has found no reliable evidence that taking paracetamol during pregnancy increases the risk of autism or attention-deficit/hyperactivity disorder (ADHD) in children. The findings, published in The BMJ on Monday, counter recent claims that have reignited global debate over the safety of the widely used painkiller.

The review, conducted by researchers from leading universities and institutions in the United Kingdom, Australia, and Spain, analysed existing scientific studies after renewed public concern following remarks by former US President Donald Trump in September. During a campaign event, Trump urged pregnant women to “fight like hell” to avoid paracetamol, claiming it was linked to autism — a statement that drew swift backlash from medical experts.

The researchers reviewed nine previous systematic studies that examined a possible connection between paracetamol use in pregnancy and later diagnoses of autism or ADHD in children. While all nine suggested an association, the team found that most of them were based on weak or flawed evidence.

According to the review, many of the earlier studies failed to adjust for key health and lifestyle factors such as genetics, parental mental health, or environmental influences — variables that could affect a child’s development. Seven of the nine reviews also warned readers to interpret their findings cautiously due to the risk of bias and confounding factors.

“Our aim was to review all the existing research to understand the quality of the evidence and help healthcare professionals communicate accurate information to expectant mothers,” said Professor Shakila Thangaratinam, a women’s health expert at the University of Liverpool and one of the study’s authors. She told Euronews Health that the overall confidence in existing evidence was rated “low to critically low,” meaning it cannot be used to establish a causal link between paracetamol and neurodevelopmental disorders.

See also  Kent Meningitis B Outbreak Cases Drop to 29, UKHSA Confirms

The review noted that when genetic and environmental influences were taken into account, any association between paracetamol use and the risk of autism or ADHD either disappeared or dropped sharply.

Paracetamol, known as acetaminophen in the United States and sold under brand names such as Tylenol, is one of the few pain and fever medications considered safe for use during pregnancy. Despite this, Trump’s comments led the US Food and Drug Administration (FDA) to recommend that manufacturers include warnings about potential neurological risks on paracetamol packaging.

The authors of the BMJ review urged more high-quality studies that examine how dosage, timing, and duration of paracetamol exposure during pregnancy might influence foetal development. They also warned against drawing conclusions or changing medical guidance based on unverified claims.

Professor Thangaratinam emphasised that decisions about medication during pregnancy should be grounded in strong evidence. “There is a sex and gender gap in science, and studies like this highlight the need for prioritising and investing in research focused on women’s health — particularly during pregnancy,” she said.

The review reinforces existing advice from global health agencies that paracetamol remains a safe and effective option for managing pain and fever in pregnancy when used as directed.

Health

AI Model Surpasses Doctors in Key Medical Decision Tests, Study Finds

Published

on

A new study by researchers at Harvard Medical School and Beth Israel Deaconess Medical Center has found that advanced artificial intelligence systems can outperform human doctors in several medical reasoning tasks, including diagnosis and emergency care decisions.

The research compared physicians with large language models across a range of clinical scenarios. According to the findings, AI systems showed stronger performance in tasks such as identifying likely diagnoses, recommending treatment steps, and making decisions in emergency department settings where information is often limited.

Arjun Manrai, a co-senior author of the study, said the results demonstrate the rapid progress of AI in healthcare. He noted that the model surpassed both earlier systems and physician benchmarks in most tests. At the same time, he cautioned that better performance in controlled settings does not guarantee improved outcomes in real-world care.

The study evaluated OpenAI’s reasoning model, released in 2024, using a mix of published clinical cases and real-world emergency department data. Researchers presented the system with patient scenarios at different stages of care, from initial triage to later admission decisions. At each step, the AI was given only the information available at that point and asked to suggest diagnoses and next actions.

The results showed that the AI consistently outperformed doctors, especially in areas requiring structured reasoning and documentation. The largest gap appeared during the triage stage, when limited information makes decision-making more difficult. As additional data became available, both AI and physicians improved in accuracy, though the AI maintained an edge in many cases.

Peter Brodeur, a co-author of the study, said traditional testing methods such as multiple-choice questions are no longer sufficient to measure progress, as many AI models now achieve near-perfect scores. He added that newer evaluation approaches are needed to track further advances.

See also  Growing Distrust of Contraceptive Pill Pushes Young Women Toward Natural Alternatives

Despite the promising results, researchers stressed that the use of AI in healthcare must be approached carefully. They warned that while a model may correctly identify a diagnosis, it could also recommend unnecessary tests or interventions that might carry risks for patients.

The study’s authors called for further trials in real clinical environments to better understand how AI tools perform in practice. They also highlighted the need for investment in infrastructure and clear frameworks to support the safe use of such technologies.

The findings come with some limitations, as the analysis focused on a specific version of the AI model, which has since been updated. Researchers said additional studies are needed to compare different systems and explore how doctors and AI can work together effectively in patient care.

Continue Reading

Health

New Study Reveals How Coffee May Help Protect the Body From Ageing

Published

on

A new study has uncovered a key biological mechanism that may explain why coffee has long been linked to healthier ageing and a lower risk of chronic disease.

Researchers at Texas A&M College of Veterinary Medicine & Biomedical Sciences found that compounds in coffee interact with a protein in the body known as NR4A1, a receptor involved in regulating stress responses, inflammation and cellular repair. The findings shed new light on how coffee may help protect the body from age-related decline.

For years, studies have associated regular coffee consumption with a longer life and reduced risk of conditions such as heart disease, cancer and cognitive decline. Until now, however, the biological processes behind those benefits have remained largely unclear.

The research team identified NR4A1 as a critical target for several naturally occurring compounds in coffee, particularly polyphenols and other polyhydroxylated substances. These compounds bind to the receptor and appear to influence how it functions.

NR4A1 acts as what scientists call a nutrient sensor, responding to dietary compounds and helping the body adapt to stress and damage. It plays an important role in controlling inflammation, maintaining energy balance and promoting tissue repair — all essential processes in healthy ageing.

Stephen Safe, one of the study’s lead researchers, said the findings provide a clearer understanding of coffee’s protective effects. He explained that NR4A1 helps limit damage when tissues are under stress, and that its absence can worsen the effects of injury or disease.

Laboratory tests showed that coffee compounds reduced cellular damage and slowed the growth of cancer cells. When researchers removed NR4A1 from the cells, those benefits disappeared, strongly suggesting that the receptor is central to coffee’s protective action.

See also  UK Ranks Lowest in Children’s Well-Being in Europe Amid Growing Concerns Over Life Satisfaction

The study also highlights that coffee’s health effects are likely driven by more than caffeine alone. Decaffeinated coffee has also been linked to improvements in learning and memory, indicating that other components, including polyphenols, may play a significant role.

Recent research has suggested that moderate consumption of caffeinated coffee may also reduce anxiety, improve attention and vigilance, and lower levels of inflammation.

Scientists caution that while the findings are promising, more research is needed to determine how significant the NR4A1 pathway is in humans and how it interacts with other biological systems.

Still, the discovery offers an important step toward understanding why coffee remains one of the most widely studied beverages in nutrition science. It also reinforces the idea that compounds found in everyday foods and drinks can play a meaningful role in supporting long-term health and resilience as people age.

Continue Reading

Health

Study Finds Rise in 11 Cancers Among Younger Adults in England

Published

on

A major study has found that rates of 11 types of cancer are increasing among younger adults in England, raising fresh concerns among researchers about factors driving the trend.

The study, conducted by the Institute of Cancer Research and Imperial College London, examined cancer diagnoses between 2001 and 2019 in adults aged 20 to 49. It identified rising incidence in a range of cancers, including breast, colorectal, pancreatic and kidney cancers.

The full list includes breast, colorectal, pancreatic, kidney, liver, gallbladder, thyroid, ovarian and endometrial cancers, as well as oral cancer and multiple myeloma, a form of blood cancer.

Researchers noted that for most of these cancers, rates have also increased among older adults, where cancer remains far more common. This suggests that some shared risk factors may be affecting multiple age groups.

Two cancers, however, stood out. Rates of colorectal and ovarian cancer rose only among younger adults, pointing to possible age-specific causes that are not yet fully understood.

Scientists examined a range of established cancer risk factors, including smoking, alcohol consumption, diet, physical activity and body weight. While these factors are known to contribute significantly to cancer risk, they do not appear to fully explain the recent rise in cases among younger people.

In fact, many of these traditional risk factors have either remained stable or improved over recent decades. Smoking rates have declined, alcohol consumption has generally fallen or levelled off, physical inactivity has decreased, and intake of red and processed meat has dropped.

Obesity was the notable exception. Rates of obesity have risen steadily across all adult age groups and remain a significant contributor to cancer risk. Even so, researchers found that obesity alone could not account for the broader increase in cancer diagnoses among younger adults.

See also  Portugal Limits Prescriptions for Popular Diabetes and Weight Loss Drugs Amid Misuse Concerns

This was particularly true for cancers commonly associated with excess body weight, such as bowel, kidney, pancreatic, liver, gallbladder and endometrial cancers. While rising obesity may be playing a role, it does not fully explain the trend.

The findings suggest that other factors may be contributing. Researchers say further investigation is urgently needed into possible causes, including environmental exposures, changes in diet or lifestyle during childhood, and other early-life influences.

They also pointed to the possibility that improved diagnostic tools, increased screening and greater public awareness may be leading to more cases being detected.

Public health experts say the study highlights the need for continued prevention efforts, particularly in tackling smoking and obesity, which remain more common in disadvantaged communities. As researchers work to better understand the causes, the rise in cancer among younger adults is likely to remain an important area of focus for health authorities.

Continue Reading

Trending